https://leverfibrose.no/blog/ https://leverfibrose.no/aasld-2026-unified-frontiers-in-liver-disease-kolestase-dag-1-steatotisk-leversykdom-dag-2-3/ 2026-01-20T14:30:20+00:00 https://leverfibrose.no/wp-content/uploads/2026/01/pexels-photo-3321794-3321794.jpg https://leverfibrose.no/steatotisk-leversykdom-okt-risiko-for-leverhendelser-og-kardiovaskulaere-utfall-saerlig-ved-metald-og-ald/ 2026-01-20T14:24:49+00:00 https://leverfibrose.no/wp-content/uploads/2026/01/g05fbaf8d0deda1f3ecd3d151d1bdf290d594a3095494102993d5666d92bc7de222e6811a868b154e3183ec665a95d0ea25e9e4aaf91960101da482fe86b75d26_1280-1426079.jpg https://leverfibrose.no/fire-av-ti-barn-og-unge-med-overvekt-eller-fedme-har-mafld/ 2026-01-20T14:21:46+00:00 https://leverfibrose.no/wp-content/uploads/2026/01/pexels-photo-5212697-5212697.jpg https://leverfibrose.no/masld-knyttet-til-okt-dodelighet-og-hjerte-og-karsykdom-men-masld-ogsa-til-kreftrelatert-dodelighet/ 2026-01-20T14:19:49+00:00 https://leverfibrose.no/pfas-kobles-til-okt-risiko-for-fettlever-hos-ungdom/ 2026-01-20T14:13:11+00:00 https://leverfibrose.no/wp-content/uploads/2026/01/pexels-photo-929385-929385.jpg https://leverfibrose.no/nordic-sld-network-workshop-27-januar-2026/ 2026-01-20T14:06:04+00:00 https://leverfibrose.no/wp-content/uploads/2026/01/SLD-network.png